Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals

Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals

<b>Background</b>: Torquetenovirus (TTV) viremia is increasingly recognized as a marker of immune competence. In the context of COVID-19, TTV viral load (VL) has been shown to predict anti-Spike antibody levels in severely immunocompromised patients. This study aimed to evaluate whether...

Full description

Saved in:
Bibliographic Details
Main Authors: Claudia Minosse, Pietro Giorgio Spezia, Valentina Mazzotta, Giulia Matusali, Silvia Meschi, Francesca Colavita, Davide Mariotti, Stefania Notari, Alessandra Vergori, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Vaccines
Subjects:
TTV
COVID-19
vaccination
anti-Spike antibodies
neutralizing antibodies
people living with HIV
Online Access:https://www.mdpi.com/2076-393X/13/2/153
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2076-393X/13/2/153

Similar Items